Pinecone Therapeutics
PrivateLast Round
Accelerator
Nov 6, 2025
Company Overview
Pinecone Therapeutics is a biotechnology company that develops one-time gene therapies for severe, inherited metabolic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B2C
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pinecone Therapeutics Comparables
Compare Pinecone Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AstraZeneca | 77% | |
| HemoShear Therapeutics | 77% | |
| Moderna, Inc. | 75% |
Pinecone Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Nov 6, 2025 |
Pinecone Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Accelerator |
| Cure by Deerfield | Accelerator |
| Qatar Development Bank | Accelerator |
| Qatar Investment Authority | Accelerator |
Pinecone Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pinecone Therapeutics's valuation, stock price, and market status.
Is Pinecone Therapeutics a public or private company?
Pinecone Therapeutics is a private company.
What is the current stock price of Pinecone Therapeutics?
Pinecone Therapeutics is a private company, so its shares have no public market price. Caplight tracks Pinecone Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pinecone Therapeutics worth (valuation)?
Valuation information for Pinecone Therapeutics is not publicly available.
Can I buy Pinecone Therapeutics stock?
Pinecone Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pinecone Therapeutics's last funding round?
Pinecone Therapeutics's most recent funding round was Accelerator on November 6, 2025.
Who are the main investors in Pinecone Therapeutics?
Key investors in Pinecone Therapeutics include Deerfield Management, Cure by Deerfield, Qatar Development Bank, Qatar Investment Authority.
Will Pinecone Therapeutics IPO soon?
No public IPO plans have been announced for Pinecone Therapeutics.
How can I track Pinecone Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Pinecone Therapeutics's shares on secondary markets.